• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌肺病:一项意大利全国性调查。

Non-tuberculous mycobacterial pulmonary disease: an Italian National survey.

作者信息

Prato Bruno Del, Altieri Alfonso Maria, Carlucci Biagio, Mori Pier Anselmo, Parrella Roberto, Stainer Anna, Giacomi Federica De, Pesci Alberto, Faverio Paola

机构信息

U.O.S.C. Pneumologia Interventistica A.O.R.N.A. Cardarelli, Napoli, Italy.

U.O.C. Broncopneumologia e Tisiologia, A.O. S. Camillo-Forlanini, Roma, Italy.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):21-25. doi: 10.36141/svdld.v35i1.6979. Epub 2018 Apr 28.

DOI:10.36141/svdld.v35i1.6979
PMID:32476876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7170062/
Abstract

The incidence of non-tuberculous mycobacteria (NTM) infection is increasing in Europe. However, a picture of Italian epidemiology and clinical practice is missing. We performed a national Italian survey involving 42 respiratory medicine departments. The NTM species more frequently isolated were , followed by and . Patients with NTM were more frequently female (57%), and over 60 years of age, with bronchiectasis and COPD as main comorbidities. Bronchoscopic samples were widely used in the diagnostic phase. Of all patients with NTM, 73% met the criteria for NTM pulmonary disease. Despite strong adherence to the guidelines, physicians found significant difficulties related to pharmacological adverse events, patients' compliance and poor outcomes. .

摘要

在欧洲,非结核分枝杆菌(NTM)感染的发病率正在上升。然而,目前尚缺乏意大利的流行病学和临床实践情况。我们在意大利开展了一项全国性调查,涉及42个呼吸内科。最常分离出的NTM菌种依次为 ,其次是 和 。NTM患者中女性更为常见(57%),年龄多在60岁以上,主要合并症为支气管扩张和慢性阻塞性肺疾病(COPD)。支气管镜检查样本在诊断阶段被广泛使用。在所有NTM患者中,73%符合NTM肺病的标准。尽管严格遵循指南,但医生们在药物不良事件、患者依从性和疗效不佳方面仍遇到了重大困难。

相似文献

1
Non-tuberculous mycobacterial pulmonary disease: an Italian National survey.非结核分枝杆菌肺病:一项意大利全国性调查。
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):21-25. doi: 10.36141/svdld.v35i1.6979. Epub 2018 Apr 28.
2
Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.比利时三个参考中心的肺部非结核分枝杆菌分离株的临床相关性:一项多中心回顾性分析。
BMC Infect Dis. 2019 Dec 17;19(1):1061. doi: 10.1186/s12879-019-4683-y.
3
[Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey].[2009 - 2010年土耳其国家结核病参考实验室分离的非结核分枝杆菌菌株分布评估]
Mikrobiyol Bul. 2012 Oct;46(4):560-7.
4
[Treatment of non-tuberculous pulmonary mycobacteriosis].[非结核分枝杆菌肺病的治疗]
Kekkaku. 2006 Jan;81(1):35-50.
5
[Non-tuberculous mycobacteriosis. What has been coming out].[非结核分枝杆菌病。最新进展]
Kekkaku. 2011 Feb;86(2):113-25.
6
A Case Series of Non-Tuberculous Mycobacterial Pulmonary Disease Masquerading as Malignancy From a Community-Based Hospital.来自一家社区医院的伪装成恶性肿瘤的非结核分枝杆菌肺病病例系列
J Med Cases. 2023 Apr;14(4):141-147. doi: 10.14740/jmc4098. Epub 2023 Apr 30.
7
Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.华盛顿州少见非结核分枝杆菌实验室分离株的物种特异性风险因素、治疗决策及临床结果
Ann Am Thorac Soc. 2017 Jul;14(7):1129-1138. doi: 10.1513/AnnalsATS.201609-731OC.
8
Profiling non-tuberculous mycobacteria in an Asian setting: characteristics and clinical outcomes of hospitalized patients in Singapore.在亚洲环境中分析非结核分枝杆菌:新加坡住院患者的特征和临床结局。
BMC Pulm Med. 2018 May 22;18(1):85. doi: 10.1186/s12890-018-0637-1.
9
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].[日本鸟分枝杆菌复合群感染控制策略:它们如何改善当前状况?]
Kekkaku. 2013 Mar;88(3):355-71.
10
Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.非结核分枝杆菌:分离模式。一项多国回顾性调查。
Int J Tuberc Lung Dis. 2004 Oct;8(10):1186-93.

引用本文的文献

1
Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against and , Two Emerging Human Pathogens.理性探索 2,4-二氨基嘧啶作为对 和 的 DHFR 抑制剂,这两种新兴的人类病原体。
J Med Chem. 2024 Nov 14;67(21):19143-19164. doi: 10.1021/acs.jmedchem.4c01594. Epub 2024 Oct 28.
2
Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group.意大利非结核分枝杆菌感染治疗的处方习惯和药物可及性:IRENE研究组的多中心调查
Infection. 2025 Feb;53(1):383-392. doi: 10.1007/s15010-024-02390-y. Epub 2024 Sep 20.
3
Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine.治疗非结核分枝杆菌感染的药物:来自意大利传染病和热带医学学会分枝杆菌研究组的叙述性综述。
Infection. 2024 Jun;52(3):737-765. doi: 10.1007/s15010-024-02183-3. Epub 2024 Feb 8.
4
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.探索慢性阻塞性肺疾病(COPD)导致患者对鸟分枝杆菌复合群(MAC)感染易感性增加的潜在免疫抑制途径。
Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077.

本文引用的文献

1
Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.非结核分枝杆菌肺病——临床管理、未满足的需求和未来展望。
Expert Rev Respir Med. 2017 Dec;11(12):977-989. doi: 10.1080/17476348.2017.1386563. Epub 2017 Oct 10.
2
Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.支气管扩张症中非结核分枝杆菌感染的特征分析
Int J Mol Sci. 2016 Nov 16;17(11):1913. doi: 10.3390/ijms17111913.
3
Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease.非结核分枝杆菌:参考实验室的流行病学模式及与肺部疾病相关的危险因素。
Epidemiol Infect. 2017 Feb;145(3):515-522. doi: 10.1017/S0950268816002521. Epub 2016 Nov 2.
4
Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014.2004年至2014年期间,意大利托斯卡纳地区从人类身上分离出的非结核分枝杆菌数量增加。
BMC Infect Dis. 2016 Feb 1;16:44. doi: 10.1186/s12879-016-1380-y.
5
Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.大环内酯类/氮杂内酯类药物治疗结节性/支气管扩张型鸟分枝杆菌复合群肺病。
Chest. 2014 Aug;146(2):276-282. doi: 10.1378/chest.13-2538.
6
Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis.鸟分枝杆菌复合体的治疗结果:一项系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):347-58. doi: 10.1007/s10096-013-1962-1. Epub 2013 Aug 25.
7
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.美国胸科学会/美国感染病学会官方声明:非结核分枝杆菌病的诊断、治疗与预防
Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416. doi: 10.1164/rccm.200604-571ST.